Menarini
125th Anniversary of Menarini
125th Anniversary of Menarini
News and Press Release
Florence, 4th-6th April 2014 - Festival dei Bambini

Florence, 27/04/2014 - Press Release

Florence, 11th February 2014 - Leucemia: “farmaco-spazzino” riduce i danni da chemioterapia

Florence 18/01/2014 - Press Release

Florence, 10/01/2014 - Press Release

OXFORD, UK and BERLIN CHEMIE/MENARINI, GERMANY, 9th December 2013

Oxford BioTherapeutics and Menarini Progress Enhanced Antibody for Acute Myeloid Leukemia as First Clinical Development Candidate in $1 Billion Oncology Investment Alliance


Wuhan (China), Ottobre 2013 - MENARINI GROUP Announces the Inauguration of its China Headquarters in Wuhan Biolake

Florence - September 11, 2013 - One cell in one billion: the new Italian technology for attacking cancer

Menarini acquires Silicon Biosystems, winner of the 2013 Leonardo award in the start-up category, for the isolation of rare cancer cells


Florence, 16th July 2013

MOUNTAIN VIEW, Calif., July 9, 2013 - VIVUS ANNOUNCES AVANAFIL PARTNERSHIP WITH MENARINI

Menarini to Launch and Market SPEDRA in 40 Countries in Europe and Abroad


Florence, 4th July 2013

18/06/2013 - MENARINI GROUP announces agreement with GILEAD SCIENCES

to commercialize Ranexa® (ranolazine) in 50 new countries


Firenze 18 giugno 2013 - Basket in carrozzina

Le Volpi Rosse Menarini approdano in “Serie B”


Rome, 14th June, 2013

Rome, 12th June, 2013

Florence, 6th June, 2013

Florence, 31st May, 2013

Company profile

Worldwide

Research & Development

Manufacturing

Italian Division - Ethical Div.

Italian Division - OTC Div.

Clinical studies

Diagnostics

Job opportunities

News and Press Releases

Pharmacovigilance

terms and conditions | site map | contact us
V.A.T. 00395270481
| Italian version | English version |
Italian version  English version
      Privacy Policy for Physicians
Privacy Policy for Pharmacist